Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-03-Speech-4-461-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110203.25.4-461-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Tuberculosis kills almost 2 million people each year, mainly in sub-Saharan Africa and in Asia. It is a scourge that highlights the inequalities between the North and the South, and the lack of resources, treatment and research available to us to halt the disease.
Our motion for a resolution points out the efforts that must be made to detect and diagnose the disease more quickly and effectively. Above all, however, it stresses the need to implement a large-scale vaccination programme, which is the only way of achieving one of the Millennium Development Goals (MDG 6) and eradicating the disease by 2050.
At the same time, it is essential for pharmaceutical research efforts to focus on this neglected and ‘uneconomical’ disease. Funding for this research must be guaranteed, for example through European Investment Bank funds. As we know, USD 3 billion are needed to conduct the WHO’s ‘Stop Tuberculosis’ programme. This is a crucial investment if we want to make progress in research and innovation and thus help to increase the support given to the poorest populations."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples